Annual CFF
$18.73 M
+$15.64 M+505.48%
March 31, 2023
Summary
- As of March 6, 2025, MDNA annual cash flow from financing activities is $18.73 million, with the most recent change of +$15.64 million (+505.48%) on March 31, 2023.
- During the last 3 years, MDNA annual CFF has fallen by -$11.91 million (-38.88%).
Performance
MDNA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$0.00
-$360.40 K-100.00%
June 30, 2023
Summary
- As of March 6, 2025, MDNA quarterly cash flow from financing activities is $0.00, with the most recent change of -$360.40 thousand (-100.00%) on June 30, 2023.
- Over the past year, MDNA quarterly CFF has stayed the same.
Performance
MDNA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$17.97 M
-$758.30 K-4.05%
June 30, 2023
Summary
- As of March 6, 2025, MDNA TTM cash flow from financing activities is $17.97 million, with the most recent change of -$758.30 thousand (-4.05%) on June 30, 2023.
- Over the past year, MDNA TTM CFF has stayed the same.
Performance
MDNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MDNA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +505.5% | 0.0% | 0.0% |
| 3 y3 years | -38.9% | 0.0% | 0.0% |
| 5 y5 years | +5008.6% | 0.0% | 0.0% |
MDNA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -83.5% | -100.0% | <-9999.0% | -17.7% | -82.8% |
| 5 y | 5-year | -38.9% | -83.5% | -100.0% | <-9999.0% | -48.1% | -82.8% |
| alltime | all time | -38.9% | -98.0% | -100.0% | <-9999.0% | -48.1% | -100.0% |
Medicenna Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $0.00(-100.0%) | $17.97 M(-4.0%) |
| Mar 2023 | $18.73 M(+505.5%) | $360.40 K(-156.8%) | $18.73 M(+1.5%) |
| Dec 2022 | - | -$635.00 K(-103.5%) | $18.45 M(-15.5%) |
| Sep 2022 | - | $18.24 M(+2306.0%) | $21.84 M(+499.7%) |
| Jun 2022 | - | $758.30 K(+803.8%) | $3.64 M(+17.7%) |
| Mar 2022 | $3.09 M(-77.6%) | $83.90 K(-97.0%) | $3.09 M(-69.6%) |
| Dec 2021 | - | $2.76 M(+6281.5%) | $10.17 M(+2.8%) |
| Sep 2021 | - | $43.20 K(-79.4%) | $9.90 M(-2.4%) |
| Jun 2021 | - | $209.30 K(-97.1%) | $10.14 M(-26.6%) |
| Mar 2021 | $13.82 M(-54.9%) | $7.17 M(+188.8%) | $13.82 M(-56.3%) |
| Dec 2020 | - | $2.48 M(+760.8%) | $31.60 M(-8.7%) |
| Sep 2020 | - | $288.20 K(-92.6%) | $34.61 M(+3.1%) |
| Jun 2020 | - | $3.89 M(-84.4%) | $33.58 M(+9.6%) |
| Mar 2020 | $30.64 M | $24.95 M(+354.4%) | $30.64 M(+434.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $5.49 M(-843.8%) | $5.73 M(+36.5%) |
| Sep 2019 | - | -$738.20 K(-178.3%) | $4.20 M(-31.6%) |
| Jun 2019 | - | $942.60 K(+2298.5%) | $6.14 M(+18.1%) |
| Mar 2019 | $5.20 M(+1317.9%) | $39.30 K(-99.0%) | $5.20 M(-5.3%) |
| Dec 2018 | - | $3.96 M(+228.8%) | $5.49 M(+257.6%) |
| Sep 2018 | - | $1.20 M(>+9900.0%) | $1.54 M(+358.9%) |
| Jun 2018 | - | $0.00(-100.0%) | $334.60 K(-8.7%) |
| Mar 2018 | $366.60 K(-96.8%) | $332.80 K(<-9900.0%) | $366.60 K(+984.6%) |
| Dec 2017 | - | -$500.00(-121.7%) | $33.80 K(-1.5%) |
| Sep 2017 | - | $2300.00(-92.8%) | $34.30 K(+7.2%) |
| Jun 2017 | - | $32.00 K(>+9900.0%) | $32.00 K(>+9900.0%) |
| Mar 2017 | $11.36 M(+89.5%) | - | - |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | $5.99 M | $0.00 | $0.00 |
FAQ
- What is Medicenna Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Medicenna Therapeutics?
- What is Medicenna Therapeutics annual CFF year-on-year change?
- What is Medicenna Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Medicenna Therapeutics?
- What is Medicenna Therapeutics quarterly CFF year-on-year change?
- What is Medicenna Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Medicenna Therapeutics?
- What is Medicenna Therapeutics TTM CFF year-on-year change?
What is Medicenna Therapeutics annual cash flow from financing activities?
The current annual CFF of MDNA is $18.73 M
What is the all time high annual CFF for Medicenna Therapeutics?
Medicenna Therapeutics all-time high annual cash flow from financing activities is $30.64 M
What is Medicenna Therapeutics annual CFF year-on-year change?
Over the past year, MDNA annual cash flow from financing activities has changed by +$15.64 M (+505.48%)
What is Medicenna Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of MDNA is $0.00
What is the all time high quarterly CFF for Medicenna Therapeutics?
Medicenna Therapeutics all-time high quarterly cash flow from financing activities is $24.95 M
What is Medicenna Therapeutics quarterly CFF year-on-year change?
Over the past year, MDNA quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Medicenna Therapeutics TTM cash flow from financing activities?
The current TTM CFF of MDNA is $17.97 M
What is the all time high TTM CFF for Medicenna Therapeutics?
Medicenna Therapeutics all-time high TTM cash flow from financing activities is $34.61 M
What is Medicenna Therapeutics TTM CFF year-on-year change?
Over the past year, MDNA TTM cash flow from financing activities has changed by $0.00 (0.00%)